Trade Summary

3 days ago, Borgeson Blake, serving as Dir at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 30,000 shares at $3.68 per share, for a total transaction value of $110,400.00. Following this transaction, Borgeson Blake now holds 6,169,863 shares of RXRX.

This sale represents a 0.48% decrease in Borgeson Blake's stake in the company.

The trade was executed on Tuesday, June 2, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 5:04 PM ET, 2 days after the trade was made.

RECURSION PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.